Frequency of genetic polymorphism for adrenergic receptor beta and cytochrome p450 2D6 enzyme, and effects on tolerability of beta-blocker therapy in heart failure with reduced ejection fraction patients: The Beta GenTURK study

Date
2016
Author
Yucel, Ceyhun
Mutlu, Hasim
Demir, Serafettin
Ergene, Oktay
YILMAZ, MEHMET BİRHAN
ZOGHİ, MEHDİ
KAYA, HAKKI
ÇAVUŞOĞLU, YÜKSEL
Aksakal, Enbiya
Metadata
Show full item record
Abstract
Objective: The present objective was to determine frequency of Arginine389Glycine (Arg389Gly) and Cytochrome p450 2D6*10 (Cyp2D6*10) polymorphism in cases of heart failure-reduced ejection fraction (HFREF), and to evaluate the influence of the polymorphisms in response to beta-blocker (BB) therapy.
URI
http://hdl.handle.net/20.500.12627/12551
https://doi.org/10.5543/tkda.2016.10733
Collections